Sharda Cropchem Final Dividend FY26 — ₹9/Share, 1.15% Yield, Record Date

The ShareBazaar Angle

FY26 net profit jumped 124% year-on-year to ₹681 crore — a spectacular headline. But part of that leap is a base effect: FY24 profit had collapsed to just ₹32 crore. Sharda Cropchem’s earnings are genuinely cyclical, yet the striking fact is that its dividend has kept rising through the volatility, backed by a cash-rich, debt-free balance sheet rather than by any single strong year. The final dividend is comfortably covered by earnings (8.4x) and operating cash flow (4.8x on the full-year payout), though free cash flow coverage is much tighter at ~1.2x because of the company’s heavy spend on product registrations.

The Board of Directors of Sharda Cropchem Limited, at its meeting held on Wednesday, 13 May 2026, considered and recommended a final dividend at the rate of ₹9.00 per equity share of face value ₹10.00 each for the financial year 2025-26. As is standard for a final dividend, the recommendation was subject to shareholder approval at the Annual General Meeting. That approval was subsequently obtained at the company’s 23rd AGM on 14 August 2026, which was conducted through video conferencing.

Why The “90%” Label Can Mislead

A dividend expressed as a percentage is always calculated on the face value (₹10 here), not the market price. So “90% dividend” simply means ₹9 per share. Against the market price of roughly ₹782, that ₹9 works out to a real yield of about 1.15% for the final dividend. Retail investors sometimes read “90%” as a 90% return — it is not. This is one of the most common misunderstandings in Indian dividend investing, and we flag it in every report.

Eligibility (Past Tense)

Because the record date of 7 August 2026 has already passed, the eligibility window is closed. Shareholders who held Sharda Cropchem shares in their demat account as of the record date were entitled to receive the ₹9.00 final dividend. Investors buying the stock after the ex-date did not qualify for this particular payout.

Sector Context

Agrochemical and specialty-chemical stocks in India are typically growth-oriented, low-yield names, with dividend yields commonly in the 0.5%–2% band. Sharda’s ~1.9% trailing yield sits at the upper end of that range for the sector, but income should not be the primary reason to own a cyclical agrochemical exporter — the total-return case rests far more on earnings recovery and product-registration growth than on the dividend cheque.

A Warning From The Next Quarter

The final dividend was recommended on 13 May 2026, before Q1 FY27 results were out. Those results (quarter ended June 2026) showed revenue up ~9% to ₹1,074 crore but net profit falling to ₹88 crore from ₹143 crore a year earlier, with operating margin compressing to ~17%. In other words, the cyclicality is still very much alive — a reminder that FY26’s peak margins may not persist.

The OCF-To-FCF Gap: Sharda’s Signature Feature

Notice the drop from ₹656 crore of operating cash to just ₹158 crore of free cash flow. That ₹445 crore of investing outflow is not factories — Sharda outsources most manufacturing. It is largely spending on product registrations and dossiers (recorded as intangible assets), which is the company’s core growth engine and also why depreciation and amortisation ran to ~₹325 crore in FY26. This is an asset-light business at the plant level but a capital-intensive one at the registration level. The practical implication for dividend investors: operating cash easily funds the dividend, but the company reinvests so heavily that free cash flow left over is modest. The dividend is genuinely funded from operations — not from borrowings or asset sales — but it competes with a large, ongoing reinvestment programme.

The Working-Capital Watch-Point

The one blemish is high debtor days of ~166 — meaning it takes the company more than five months, on average, to collect from customers. This is structural for an exporter selling across Europe, LATAM and other regulated markets, but it ties up cash in receivables and is a key reason operating cash flow can lag reported profit in any given year. It is not a debt problem; it is a cash-conversion-timing issue worth monitoring.

Overall Verdict: Sustainable

On balance, we classify the dividend as Sustainable. Three of the four tests are clearly strong, and the only amber flag — free cash flow coverage of ~1.2x — reflects the company’s choice to reinvest heavily in product registrations, not any weakness in cash generation. The near debt-free balance sheet and large reserves give management the flexibility to hold the dividend steady even in a down year, as FY24 demonstrated. The realistic risk is not a permanent cut but a payout that may not keep growing at the FY26 pace if earnings normalise from their current peak.

How Sharda Stands Out

Two things distinguish Sharda within the peer set. First, its debt-free balance sheet compares favourably with more leveraged names in the space. Second, its asset-light, registration-driven model gives it high return ratios (ROCE ~30%) but also chunky intangible amortisation and long receivables. On dividend yield it screens at the higher end of a generally low-yield sector, but the trade-off is meaningfully higher earnings volatility than a diversified peer.

Interpreting The Concentration

With promoters holding almost three-quarters of the company, roughly ₹61 crore of the ₹81 crore final-dividend cheque flows to the promoter family. This is not unusual for a founder-run Indian business, and dividends are paid equally per share, so minority shareholders receive exactly the same ₹9 per share. The alignment is broadly positive: promoters benefit most when the dividend rises, which incentivises steady distributions. The flip side is that a high, stable promoter stake means minority investors have limited influence over capital-allocation choices — whether to pay dividends, reinvest, or buy back stock.

How Dividends Are Taxed In India

Since the abolition of the Dividend Distribution Tax in FY21, dividends are taxable in the hands of the shareholder at their applicable income-tax slab rate. The company also deducts TDS at 10% under Section 194 if the total dividend paid to a resident shareholder in a financial year exceeds ₹5,000 (TDS is 20% where PAN is not furnished). The TDS is not an extra cost — it is adjustable against your final tax liability when you file your return.

Worked Example (1,000 Shares, 30% Slab)

• Shares held: 1,000
• Final dividend: ₹9.00 per share
• Gross dividend: 1,000 × ₹9 = ₹9,000
• TDS @10% (as >₹5,000): ₹900 deducted at source (adjustable)
• Tax @30% slab on ₹9,000: ₹2,700
• Net dividend in hand: ₹9,000 − ₹2,700 = ₹6,300
• Effective post-tax yield (on CMP ₹782): ~0.81%

Illustrative only. Actual tax depends on your total income and slab. Investors in lower slabs (5%/20%) or with total annual dividends below ₹5,000 will pay less or have no TDS.

• 1. Earnings cyclicality. Profit swung from ₹349 Cr (FY22) to ₹32 Cr (FY24) to ₹681 Cr (FY26). Such volatility can pressure the payout ratio and any future dividend growth.
• 2. Margin normalisation. FY26’s 20% operating margin was a peak; Q1 FY27 already showed compression to ~17% with profit down ~38% YoY. If margins mean-revert, so may the dividend’s growth trajectory.
• 3. Currency and export exposure. A large share of revenue comes from Europe, LATAM and other overseas markets, exposing earnings to currency swings and global agrochemical pricing.
• 4. High receivables. Debtor days of ~166 tie up cash and can cause operating cash flow to lag reported profit in weaker years.
• 5. Registration and regulatory dependence. The business model rests on securing and maintaining product registrations; delays, rejections or regulatory changes in key markets could hit growth and cash generation.
• 6. Commodity input costs. Management has itself flagged expected increases in procurement costs, which could squeeze margins if not passed through in pricing.

• 1. Operating margin trend. Watch whether the ~17% seen in Q1 FY27 stabilises or slides further from the FY26 peak of 20%.
• 2. Free cash flow vs registration spend. Track how much operating cash is absorbed by product-registration investment, since that determines how much is left for dividends.
• 3. Debtor days. Any improvement below ~150 days would meaningfully strengthen cash conversion; further deterioration would be a warning.
• 4. Payout-ratio discipline. Note whether management holds the payout in its normal ~16–27% band or lets it spike again as in FY24.
• 5. Dividend guidance and quarterly results. Watch upcoming interim-dividend declarations and quarterly earnings for the direction of FY27 profit.
• 6. Currency and key-market demand. Monitor euro/rupee moves and demand in Europe and LATAM, the company’s largest markets.